3 most recent stories to be displayed on the SoP homepage.
Capio Biosciences, Inc., a cancer diagnostic biotech startup, is partnering with the University of Wisconsin–Madison on research that will further develop novel technology in cancer detection. The Research Service Agreement (RSA) will support the research of …
Jiaoyang Jiang, assistant professor in the Pharmaceutical Sciences Division, is the principal investigator of a second R01 grant from the National Institutes of Health (NIH) to study the critical role of a human enzyme (O-GlcNAcase)
Faculty, staff, alumni, and students were in attendance to hear 2017 Busse Lecturer, Dr. Allan Hoffman Professor Emeritus, Department of Bioengineering University of Washington, Seattle, deliver presentations on
Dave Mott, professor and Chair, Social and Administrative Sciences Division, is an invited speaker for The Evidence-Based Health Policy Project (EBHPP) roundtable on falls research by UW-Madison faculty and their teams.
On behalf of the Class of 2020, second year PharmD students Griffin Budde and Devin Jones are extending an invitation to all faculty, staff, and alumni to attend the upcoming picnic.
Jennifer E. Golden, assistant professor in the Pharmaceutical Sciences Division and Associate Director, Medicinal Chemistry Center, was selected to deliver a podium talk at the 2017 Medicinal Chemistry
Dr. Allan Hoffman Professor Emeritus, Department of Bioengineering University of Washington, Seattle, will deliver the 2017 Busse Lectures on Thursday and Friday, September 14 and 15.
A COPD CARE (Chronic Obstructive Pulmonary Disease Coordinated Access to Reduce Exacerbations) service developed by Ed Portillo, assistant faculty associate in the Pharmacy Practice Division, has been selected as a Clinical Pharmacy Practice Office (CPPO) …
Several of the School’s graduate students completed the 2nd Annual Degree Dash, a fun run hosted by the Graduate School.
Arash Bashirullah, associate professor in the Pharmaceutical Sciences Division, is the principal investigator of a new R01 award from the National Institutes of Health (NIH). The $1.2M award will fund studies of exocytosis